Tds Tradings Services
⚠️ High Risk
FEI: 3004003755 • Mumbai, Maharashtra • INDIA
FEI Number
3004003755
Location
Mumbai, Maharashtra
Country
INDIAAddress
#204 Crystal Plaza, , Mumbai, Maharashtra, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/6/2003 | 62TLB06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 11/6/2003 | 60SLB22FAMOTIDINE (ANTACID) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 11/6/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 11/6/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 8/11/2003 | 65QCA65TIZANIDINE HCL (RELAXANT) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 8/11/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 179AGR RX | New Orleans District Office (NOL-DO) |
| 8/8/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 8/8/2003 | 62TCP02LANSOPRAZOLE (ANTI-SECRETORY) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 8/7/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/7/2003 | 61NCA37LITHIUM CARBONATE (ANTI-DEPRESSANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 7/21/2003 | 61PIB55METFORMIN HCL (ANTI-DIABETIC) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 7/21/2003 | 61JDB08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 7/21/2003 | 62ODB14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II) | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 6/30/2003 | 61GCA85OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 6/30/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 179AGR RX | New Orleans District Office (NOL-DO) |
| 6/30/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 179AGR RX | New Orleans District Office (NOL-DO) |
| 6/27/2003 | 60SCH99ANTACID, N.E.C. | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 6/27/2003 | 66VAY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/26/2003 | 66VAY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/26/2003 | 86MSISOLUTION, CLEANING/LUBRICATING, ARTICIFIAL EYE | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/26/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/26/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 5/29/2003 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 5/21/2003 | 64BCA25HYDROCHLOROTHIAZIDE (DIURETIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 5/12/2003 | 61NCY76PAROXETINE (ANTI-DEPRESSANT) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 5/12/2003 | 66VCB99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 5/12/2003 | 66VBY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 5/7/2003 | 66VCB99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Tds Tradings Services's FDA import refusal history?
Tds Tradings Services (FEI: 3004003755) has 28 FDA import refusal record(s) in our database, spanning from 5/7/2003 to 11/6/2003.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Tds Tradings Services's FEI number is 3004003755.
What types of violations has Tds Tradings Services received?
Tds Tradings Services has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Tds Tradings Services come from?
All FDA import refusal data for Tds Tradings Services is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.